Examples of ongoing sipuleucel-T combination studies
| Trial | National clinical trial identifier | Statusa |
|---|---|---|
| Concurrent vs. sequential sipuleucel-T and abiraterone | NCT01487863 | Randomized phase II, Reported in 2015 [44] |
| Sipuleucel-T +/- RT | NCT01807065 | Randomized Phase II, Recruiting, Expected completion date June 2017 |
| Sipuleucel-T +/- pTVG-HP DNA booster vaccine | NCT01706458 | Randomized pilot study, Recruiting, Expected completion date December 2016 |
| Sipuleucel-T + indoximod | NCT01560923 | Randomized phase II Recruiting, Expected completion date December 2016 |
| Sipuleucel-T +/- ipilimumab | NCT01804465 | Randomized phase II, Recruiting, Expected completion date December 2017 |
| Sipuleucel-T +/- radium - 223 | NCT02463799 | Randomized phase II, Recruiting, Expected completion date December 2018 |
a As determined by ClinicalTrials.gov accessed October 31, 2016